AzTrials
AzTrials

Anterior Segment DisordersNCT04314180

Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis

An observational study of Anterior Segment Disorders and Artificial Intelligence, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Slit-lamp images are widely used in ophthalmology for the detection of cataract, keratopathy and other anterior segment disorders. In real-world practice, the quality of slit-lamp images can be unacceptable, which can undermine diagnostic accuracy and efficiency. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
Taking slit-lamp images
Type of treatment
Medical device
How many people
300 participants
Where
1 siteChina
Study dates
1 Feb 2020to 1 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Inclusion Criteria: - Patients should be aware of the contents and signed for the informed consent. Exclusion Criteria: - 1. Patients who cannot cooperate with a photographer such as some paralytics, the patients with dementia and severe psychopaths. - 2. Patients who do not agree to sign informed consent

Who may be able to join

  • Patients should be aware of the contents and signed for the informed consent.

Who cannot join

  • 1. Patients who cannot cooperate with a photographer such as some paralytics, the patients with dementia and severe psychopaths.
  • 2. Patients who do not agree to sign informed consent.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510060

Other trials in China

About this study

Official title: Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis: A Clinical Trial

Slit-lamp images are widely used in ophthalmology for the detection of cataract, keratopathy and other anterior segment disorders. In real-world practice, the quality of slit-lamp images can be unacceptable, which can undermine diagnostic accuracy and efficiency. Here, the researchers established and validated an artificial intelligence system to achieve automatic quality assessment of slit-lamp images upon capture. This system can also provide guidance to photographers according to the reasons for low quality.

Being tested
Taking slit-lamp images

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Taking slit-lamp imagesDevice

    The participant only needs to take several slit-lamp images as usual.

Study groups in NCT04314180
Study groupRoleWhat they receive
Slit-lamp image quality assessmentDevice: an artificial intelligence system for quality assessment of slit-lamp images. These patients are enrolled in primary healthcare units or the AI clinic at Zhongshan Ophthalmic Center
Receives: Device: Taking slit-lamp images

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance of artificial intelligence system for distinguish between good image quality and poor image quality

    Area under the receiver operating characteristic curves, sensitivity, specificity, positive and negative predictive values,accuracy

    Measured: 3 months

Secondary outcomes (1)
  1. The comparison of the performance for previous artificial intelligence diagnostic system with slit-lamp images of different image quality

    Cohen's kappa coefficient, P value and other related statistic results

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2020
  2. Study start1 Feb 2020
  3. Primary completion1 Jul 2020 (estimated)
  4. Study completion1 Jul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04314180
Sponsor's protocol ID
IMAQUA2020-China-02
Status last verified
Mar 2020
First submitted
16 Mar 2020
Last updated
19 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anterior Segment Disorders and Artificial Intelligence, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance of artificial intelligence system for distinguish between good image quality and poor image quality (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in